A dynamic COVID-19 immune signature includes associations with poor prognosis

Laing, Adam G., Lorenc, Anna, del Molino del Barrio, Irene, Das, Abhishek, Fish, Matthew, Monin, Leticia, Muñoz-Ruiz, Miguel, McKenzie, Duncan R. +42 more·2020·Nature Medicine
DOI 10.1038/s41591-020-1038-6

Cited by (953)

Items 501–600 of 953

  1. Evidence of Long-Lasting Humoral and Cellular Immunity against SARS-CoV-2 Even in Elderly COVID-19 Convalescents Showing a Mild to Moderate Disease Progression
    Bastian Fischer, Christopher Lindenkamp, Christoph Lichtenberg, Ingvild Birschmann, Cornelius Knabbe, Doris Hendig · 2021 · Life
  2. Machine learning in postgenomic biology and personalized medicine
    Animesh Ray · 2022 · Wiley Interdisciplinary Reviews Data Mining and Knowledge Discovery
  3. Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction
    Rahnuma Ahmad, Mainul Haque · 2022 · Vaccines
  4. Alterations of blood monocyte subset distribution and surface phenotype are linked to infection severity in COVID‐19 inpatients
    David Haschka, Verena Petzer, Francesco Robert Burkert, Gernot Fritsche, Sophie Maria Wildner, Rosa Bellmann‐Weiler, Piotr Tymoszuk, Günter Weiß · 2022 · European Journal of Immunology
  5. Immunouniverse of SARS-CoV-2
    Dennis Jiménez, Marbel Torres Arias · 2022 · Immunological Medicine
  6. Single-cell immune profiling reveals long-term changes in myeloid cells and identifies a novel subset of CD9+ monocytes associated with COVID-19 hospitalization
    William J. Pandori, Lindsey E. Padgett, Ahmad Alimadadi, Norma A. Gutierrez, Daniel J. Araujo, Christine J. Huh, Claire E. Olingy, Huy Q. Dinh, Runpei Wu, Pandurangan Vijayanand et al. · 2022 · Journal of Leukocyte Biology
  7. The impact of maternal SARS‐CoV‐2 vaccination and first trimester infection on feto‐maternal immune responses
    Lillian J. Juttukonda, Elisha M. Wachman, Jeffery O. Boateng, Katherine Clarke, Jennifer E Snyder-Cappione, Elizabeth S. Taglauer · 2022 · American Journal of Reproductive Immunology
  8. Durable CD8 T Cell Memory against SARS-CoV-2 by Prime/Boost and Multi-Dose Vaccination: Considerations on Inter-Dose Time Intervals
    Ambra Natalini, Sonia Simonetti, Carmel Sher, Ugo D’Oro, Adrian Hayday, Francesca Di Rosa · 2022 · International Journal of Molecular Sciences
  9. SARS-CoV-2 infection of intestinal epithelia cells sensed by RIG-I and DHX-15 evokes innate immune response and immune cross-talk
    Lijuan Zhang, Yize Zhang, Ruiqin Wang, Xiaoning Liu, Jinmeng Zhao, Masato Tsuda, You Li · 2023 · Frontiers in Cellular and Infection Microbiology
  10. COVID-19 Related Cardiovascular Comorbidities and Complications in Critically Ill Patients: A Systematic Review and Meta-analysis
    Michael Koeppen, Peter Rosenberger, Harry Magunia · 2021 · Clinical Medicine Insights Circulatory Respiratory and Pulmonary Medicine
  11. Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease
    Alexander M. Xu, Dalin Li, Joseph E. Ebinger, Emebet Mengesha, Rebecca Elyanow, Rachel Gittelman, Heidi Chapman, Sandy Y. Joung, Gregory J. Botwin, Valeriya Pozdnyakova et al. · 2022 · Frontiers in Immunology
  12. COVID-19 patients exhibit unique transcriptional signatures indicative of disease severity
    Andrea R. Daamen, Prathyusha Bachali, Catherine A. Bonham, Lindsay Somerville, Jeffrey M. Sturek, Amrie C. Grammer, Alexandra Kadl, Peter E. Lipsky · 2022 · Frontiers in Immunology
  13. The spatio-temporal landscape of lung pathology in SARS-CoV-2 infection
    André F. Rendeiro, Hiranmayi Ravichandran, Yaron Bram, Steven Salvatore, Alain Borczuk, Olivier Elemento, Robert E. Schwartz · 2020 · medRxiv
  14. A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcome
    Vadim Demichev, Pinkus Tober‐Lau, Tatiana Nazarenko, Charlotte Thibeault, Harry J. Whitwell, Oliver Lemke, Annika Röhl, Anja Freiwald, Łukasz Szyrwiel, Daniela Ludwig et al. · 2020 · medRxiv
  15. mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challenge
    Michelle Meyer, Yuan Wang, Darin K. Edwards, Gregory R. Smith, Aliza B. Rubenstein, Palaniappan Ramanathan, Chad E. Mire, Colette A. Pietzsch, Xi Chen, Yongchao Ge et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  16. Sarcoidosis-related autoimmune inflammation in COVID-19 convalescent patients
    Artem Rubinstein, I. V. Kudryavtsev, Anna M. Malkova, J. T. Mammedova, Dmitry Isakov, Irina Isakova–Sivak, Dmitry Anatolievich Kudlay, Anna Andreevna Starshinova · 2023 · Frontiers in Medicine
  17. Chemokine receptors in COVID-19 infection
    Claudia Gutierrez-Chavez, Shalom Aperrigue-Lira, Brando Ortiz-Saavedra, Irmia Paz · 2024 · International review of cytology
  18. Adaptive immune responses to SARS-CoV-2
    Donald N. Forthal · 2021 · Advanced Drug Delivery Reviews
  19. Infection‐induced inflammation from specific inborn errors of immunity to COVID‐19
    Cheng‐Lung Ku, I‐Ting Chen, Ming‐Zong Lai · 2021 · FEBS Journal
  20. Central Nervous System Effects of COVID-19 in People with HIV Infection
    Michael J. Peluso, Joanna M. Hellmuth, Felicia C. Chow · 2021 · Current HIV/AIDS Reports
  21. SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response
    Federico Alberici, Stefania Affatato, Daniele Moratto, Federica Mescia, Elisa Delbarba, Alice Guerini, Martina Tedesco, Peter D. Burbelo, Roberta Zani, Ilaria Castagna et al. · 2022 · Journal of Nephrology
  22. Comprehensive Analysis of the ILCs and Unconventional T Cells in Virus Infection: Profiling and Dynamics Associated with COVID-19 Disease for a Future Monitoring System and Therapeutic Opportunities
    Elena Lo Presti, Andrea De Gaetano, Giovanni Pioggia, Sebastiano Gangemi · 2022 · Cells
  23. Regulatory T Cells in Immunopathogenesis and Severity of COVID-19: A Systematic Review
    Sam Alahyari, Mohsen Rajaeinejad, Hasan Jalaeikhoo, Davar Amani · 2022 · Archives of Iranian Medicine
  24. Cellular heterogeneity in disease severity and clinical outcome: Granular understanding of immune response is key
    Kriti Khare, Rajesh Pandey · 2022 · Frontiers in Immunology
  25. The Connection between Gut and Lung Microbiota, Mast Cells, Platelets and SARS-CoV-2 in the Elderly Patient
    Giovanna Traina · 2022 · International Journal of Molecular Sciences
  26. Severe Clinical Worsening in COVID-19 and Potential Mechanisms of Immune-Enhanced Disease
    John P. Hussman · 2021 · Frontiers in Medicine
  27. SARS-CoV-2 Infection Drives a Glycan Switch of Peripheral T Cells at Diagnosis
    Inês Alves, Manuel M. Vicente, Joana Gaifem, Ângela Fernandes, Ana M. Dias, Cláudia S. Rodrigues, José Carlos Oliveira, Nair Seixas, Luís Malheiro, Miguel Araújo Abreu et al. · 2021 · The Journal of Immunology
  28. Elucidating T Cell and B Cell Responses to SARS-CoV-2 in Humans: Gaining Insights into Protective Immunity and Immunopathology
    Aaruni Khanolkar · 2021 · Cells
  29. Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B2 receptor antagonism
    Constanze A. Jakwerth, Martin Feuerherd, Ferdinand M. Guerth, Madlen Oelsner, Linda Schellhammer, Johanna Giglberger, Lisa Pechtold, Claudia Jerin, Luisa M. Kugler, Carolin Mogler et al. · 2022 · Journal of Molecular Medicine
  30. Elevated Salivary Inflammatory Biomarkers are Associated with SARS-CoV-2 Infection Severity
    Hanadi Abdullah Alwafi, Soad Shaker Ali, Sunil Babu Kotha, Layla Waleed Abuljadayel, Maha Ibrahim, Ibrahim Noor Elahi, Hebah Abdullah Alwafi, Mohammed Saad Almuhayawi, Matthew Finkelman, Nagla A. El‐Shitany · 2022 · Canadian Journal of Infectious Diseases and Medical Microbiology
  31. Are T cells helpful for COVID-19: the relationship between response and risk
    Diane E. Griffin · 2020 · Journal of Clinical Investigation
  32. The therapeutic potential of gelsolin in attenuating cytokine storm, ARDS, and ALI in severe COVID-19
    Juan Zhi, Kaixuan Zhao, Juhui Liu, Dong Liang Yang, Xiaoming Deng, Jin Xu, Haoyue Zhang · 2024 · Frontiers in Pharmacology
  33. The impact of aging and COVID-19 on our immune system: a high-resolution map from single cell analysis
    Jing Yang, Hao Li · 2020 · Protein & Cell
  34. Prognostic peripheral blood biomarkers at ICU admission predict COVID-19 clinical outcomes
    Melina Messing, Mypinder S. Sekhon, Michael R. Hughes, Sophie K. Stukas, Ryan L. Hoiland, Jennifer Gradi Cooper, Nyra Ahmed, Mark Stephen Hamer, Yicong Li, Samuel B. Shin et al. · 2022 · Frontiers in Immunology
  35. A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19
    Lin Xia, Lunzhi Yuan, Ya-hong Hu, Junyi Liu, Guo-Sheng Hu, Ruoyao Qi, Tian-ying Zhang, Hualong Xiong, Zaozao Zheng, Hong-wei Lin et al. · 2023 · Cellular and Molecular Immunology
  36. Lymphopenia in COVID-19: γδ T Cells-Based Therapeutic Opportunities
    Elena Lo Presti, Francesco Dieli, Serena Meraviglia · 2021 · Vaccines
  37. Les facteurs pronostiques dans la Covid-19
    Marion Müller, I. Bulubas, Thomas Vogel · 2021 · NPG. Neurologie, psychiatrie, gériatrie/NPG
  38. Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir
    Yi‐Hao Chan, Barnaby Edward Young, Siew‐Wai Fong, Ying Ding, Yun Shan Goh, Rhonda Sin‐Ling Chee, Seow Yen Tan, Shirin Kalimuddin, Paul Anantharajah Tambyah, Yee‐Sin Leo et al. · 2021 · Frontiers in Immunology
  39. Long‐term SARS‐CoV‐2‐specific and cross‐reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology
    Ida Laurén, Sebastian Havervall, Henry Ng, Martin Lord, Aleksandra Pettke, Nina Greilert‐Norin, Lena Gabrielsson, Aikaterini Chourlia, Catarina Amoêdo‐Leite, Vijay Sai Josyula et al. · 2022 · Immunity Inflammation and Disease
  40. A biomarker assay to risk-stratify patients with symptoms of respiratory tract infection
    Shahid Husain, Andrew T. Sage, Lorenzo Del Sorbo, Marcelo Cypel, Tereza Martinu, S. Juvet, Andrea Mariscal, Julie Korol Wright, B.T. Chao, Alaa A. Shamandy et al. · 2022 · European Respiratory Journal
  41. Immune cell population and cytokine profiling suggest age dependent differences in the response to SARS-CoV-2 infection
    Larraitz Aragón, Andrea Iribarren-López, Ainhoa Alberro, Leire Iparraguirre, Miguel Von Wichmann, José María Marimón, Nagore Saiz-Calderon, Julia Agudo, M. Isabel Gálvez, M. Carmen Cipitria et al. · 2023 · Frontiers in Aging
  42. Translational Research in the Time of COVID-19—Dissolving Boundaries
    Jonathan D. Edgeworth, Rahul Batra, Gaia Nebbia, Karen N. Bisnauthsing, Eithne M.E. MacMahon, Malur Sudhanva, Sam T Douthwaite, Simon D. Goldenberg, Geraldine A. O’Hara, Manu Shankar‐Hari et al. · 2020 · PLoS Pathogens
  43. SARS-CoV-2 infection induces germinal center responses with robust stimulation of CD4 T follicular helper cells in rhesus macaques
    Sonny R. Elizaldi, Y. S. Lakshmanappa, Jamin W. Roh, B. Schmidt, Timothy D. Carroll, Kourtney D. Weaver, Justin C. Smith, J. Deere, Joseph C. Dutra, M. Stone et al. · 2020 · bioRxiv
  44. Severely ill COVID-19 patients display augmented functional properties in SARS-CoV-2-reactive CD8 + T cells
    Anthony Kusnadi, Ciro Ramírez-Suástegui, Vicente Fajardo, Serena Chee, Benjamin J. Meckiff, Hayley A. Simon, Emanuela Pelosi, Grégory Seumois, Ferhat Ay, Pandurangan Vijayanand et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  45. A proteomic survival predictor for COVID-19 patients in intensive care
    Vadim Demichev, Pinkus Tober‐Lau, Tatiana Nazarenko, Simran Kaur Aulakh, Harry J. Whitwell, Oliver Lemke, Annika Röhl, Anja Freiwald, Mirja Mittermaier, Łukasz Szyrwiel et al. · 2021 · medRxiv
  46. Severe COVID-19 infection is associated with aberrant cytokine production by infected lung epithelial cells rather than by systemic immune dysfunction
    S. Rouhani, Jonathan A. Trujillo, A. Pyzer, Jovian Yu, Jessica L. Fessler, Alexandra Cabanov, Emily F. Higgs, Kyle R Cron, Y. Zha, Yihao Lu et al. · 2021 · medRxiv
  47. Investigational Use of Mesenchymal Stem/Stromal Cells and Their Secretome as Add-On Therapy in Severe Respiratory Virus Infections: Challenges and Perspectives
    Sabrina Mattoli, Matthias Schmidt · 2023 · Advances in Therapy
  48. SARS-CoV-2 induced immune perturbations in infants vary with disease severity and differ from adults’ responses
    Djamel Nehar-Belaid, Asunción Mejías, Zhaohui Xu, Radu Marcheş, Rushil Yerrabelli, Chen Guo, Sara E. Mertz, Fang Ye, Pablo J. Sánchez, John S. Tsang et al. · 2025 · Nature Communications
  49. Emerging roles of basophils in the resolution of acute respiratory distress syndrome
    Seiko Takasawa, Tomoya Tateishi, Jun Sugihara, Sho Shibata, Junya Ito, Masaru Ito, Koki Hata, Sachiko Miyake, Hajime Karasuyama, Kensuke Miyake et al. · 2025 · European Respiratory Journal
  50. Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19
    Marcel S. Woo, Friedrich Haag, Axel Nierhaus, Dominik Jarczak, Kevin Roedl, Christina Mayer, Thomas Theo Brehm, Marc van der Meirschen, Annette Hennigs, Maximilian Christopeit et al. · 2021 · iScience
  51. In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection
    Alessandra Romano, Nunziatina Laura Parrinello, Martina Barchitta, Rosy Manuele, Fabrizio Puglisi, Andrea Maugeri, Alessandro Barbato, Anna Maria Triolo, Cesarina Giallongo, Daniele Tibullo et al. · 2022 · Scientific Reports
  52. Pathological Roles of Pulmonary Cells in Acute Lung Injury: Lessons from Clinical Practice
    Noriyuki Enomoto · 2022 · International Journal of Molecular Sciences
  53. Identifying potential pharmacological targets and molecular pathways of Meliae cortex for COVID-19 therapy
    Shakeel Ahmad Khan, Terence K. Lee · 2023 · Frontiers in Immunology
  54. COVID-19 patients display changes in lymphocyte subsets with a higher frequency of dysfunctional CD8lo T cells associated with disease severity
    L. Onofrio, Constanza Marín, J. Dutto, María Belén Brugo, R. E. Baigorrí, Sabrina N. Bossio, J. N. Quiróz, L. Almada, Federico N. Ruiz Moreno, Carolina Olivera et al. · 2023 · Frontiers in Immunology
  55. Type I and type III interferons: From basic biology and genetics to clinical development for COVID-19 and beyond
    Evangelos Andreakos · 2024 · Seminars in Immunology
  56. SARS-CoV-2 infection elucidates features of pregnancy-specific immunity
    Dong Sun Oh, Eunha Kim, Guangqing Lu, Rachelly Normand, Lydia L. Shook, Amanda E. Lyall, Olyvia J. Jasset, Stepan Demidkin, Emily Gilbert, Joon Mee Kim et al. · 2024 · Cell Reports
  57. Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patients
    Prashant Ramesh Tembhare, Harshini Sriram, Gaurav Chatterjee, Twinkle Khanka, Anant Ganesh Gokarn, Sumeet Prakash Mirgh, Akhil Rajendra, Anumeha Chaturvedi, Sitaram Ghogale, Nilesh Deshpande et al. · 2021 · Immunology and Cell Biology
  58. Stratification of COVID-19 patients based on quantitative immune-related gene expression in whole blood
    Josefine Persson, Björn Andersson, Suzanne van Veen, Mariëlle C. Haks, Ogonna Obudulu, Sara Torkzadeh, Tom H. M. Ottenhoff, Nelly Kanberg, Magnus Gisslén, Lars‐Magnus Andersson et al. · 2022 · Molecular Immunology
  59. A virological view of tenascin-C in infection
    Lorena Zuliani‐Alvarez, Anna Maria Piccinini · 2022 · American Journal of Physiology-Cell Physiology
  60. Bifurcated monocyte states are predictive of mortality in severe COVID-19
    Anthony Richard Cillo, Ashwin Somasundaram, Feng Shan, Carly Cardello, Creg J. Workman, Georgios D. Kitsios, Ayana T. Ruffin, Sheryl R. Kunning, Caleb Lampenfeld, Sayali Onkar et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  61. Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection
    Jane Alexandra Shaw, Stephanus Theron Malherbe, Gerhard Walzl, Nelita du Plessis · 2023 · Frontiers in Immunology
  62. Flow cytometry for extracellular vesicle characterization in COVID-19 and post-acute sequelae of SARS-CoV-2 infection
    Marialaura Fanelli, Vita Petrone, Rossella Chirico, Claudia Maria Radu, Antonella Minutolo, Claudia Matteucci · 2024 · Extracellular Vesicles and Circulating Nucleic Acids
  63. Comparative Study of Cytokine Profiles in SARS-CoV-2 Delta and Omicron Variants
    Michaela Krivosova, Juliana Hanusrichterová, Vincent Lučanský, Marek Samec, Anna Bobčáková, Eva Baranovičová, Matúš Dohál, Juraj Mokrý, Mária Škereňová, Péter Lipták et al. · 2025 · Bratislavské lekárske listy/Bratislava medical journal
  64. Clinical Value of Tocilizumab in Reducing Mortality in Refractory Septic Shock in Children with Hematologic and Non-Hematologic Diseases
    En‐Pei Lee, Jainn‐Jim Lin, Shih‐Hsiang Chen, Oi‐Wa Chan, Ya-Ting Su, Man‐Ru Hsiao, Shao‐Hsuan Hsia, Han‐Ping Wu · 2025 · Cells
  65. Development of protective immunity against African swine fever depends on host-environment interactions
    Emilia Radulovic, Kemal Mehinagic, Tsering Monika Wüthrich, Markus Hilty, Artur Summerfield, Nicolas Ruggli, Charaf Benarafa · 2025 · Frontiers in Veterinary Science
  66. Response to pegylated interferon in a COVID‐19–positive elderly woman with primary myelofibrosis treated with ruxolitinib
    Arthur Edward Frankel, Renuka Reddy, Kayla R DeSuza, Khaled Deeb, Aaron F. Carlin, Davey Smith, Yushuang Xie, Eknath Naik, Richard T. Silver, Hans Carl Hasselbalch · 2021 · Clinical Case Reports
  67. Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic
    Jonny Jonny, Terawan Agus Putranto, Raoulian Irfon, Enda Cindylosa Sitepu · 2022 · Frontiers in Immunology
  68. SARS-CoV-2 infection causes prolonged cardiomyocyte swelling and inhibition of HIF1α translocation in an animal model COVID-19
    Daems, Margo, Liesenborghs, Laurens, Boudewijns, Robbert, Simmonds, Steven J., Kraisin, Sirima, Van Wauwe, Jore, Cuijpers, Ilona, Raman, Jana, Geuens, Nadèche, Buyten, Tina Van et al. · 2022 · Frontiers in Cardiovascular Medicine
  69. Different cytokine and chemokine profiles in hospitalized patients with COVID-19 during the first and second outbreaks from Argentina show no association with clinical comorbidities
    Laura Almada, Sofia Carla Angiolini, Nicolás Daniel Dho, Jeremías Dutto, Yamila Gazzoni, Clarisa Manzone-Rodríguez, Constanza Marín, Nicolás Eric Ponce, Daniela Soledad Arroyo, Juan N. Quiroz et al. · 2023 · Frontiers in Immunology
  70. Relationship between Vitamin D and Immunity in Older People with COVID-19
    Fulvio Lauretani, Marco Salvi, Irene Zucchini, Crescenzo Testa, Chiara Cattabiani, Arianna Arisi, Marcello Giuseppe Maggio · 2023 · International Journal of Environmental Research and Public Health
  71. Intestinal IL-1β Plays a Role in Protecting against SARS-CoV-2 Infection
    Jöran Lücke, Fabian Heinrich, Jakob Malsy, Nicholas Meins, Josa Schnell, Marius Böttcher, Mikołaj Nawrocki, Tao Zhang, Franziska Bertram, Morsal Sabihi et al. · 2023 · The Journal of Immunology
  72. Single-cell RNA-seq public data reveal the gene regulatory network landscape of respiratory epithelial and peripheral immune cells in COVID-19 patients
    Lin Zhang, Hafumi Nishi, Kengo Kinoshita · 2023 · Frontiers in Immunology
  73. Whole blood transcriptome signature predicts severe forms of COVID-19: Results from the COVIDeF cohort study
    Roberta Armignacco, Nicolas Carlier, Anne Jouinot, Maria Francesca Birtolo, Daniel De Murat, Florence Tubach, Pierre Hausfater, Tabassome Simon, Guy Gorochov, Valérie Pourcher et al. · 2024 · Functional & Integrative Genomics
  74. Time-resolved scRNA-seq reveals transcription dynamics of polarized macrophages with influenza A virus infection and antigen presentation to T cells
    Jiapei Yu, Congcong Shang, Xiaoyan Deng, Ju Jia, Xiao Shang, Zeyi Wang, Ying Zheng, Rongling Zhang, Yeming Wang, Hui Zhang et al. · 2024 · Emerging Microbes & Infections
  75. Investigating the relationship between lymphocyte cells apoptosis and DNA damage and oxidative stress and therapeutic and clinical outcomes of COVID-19 elderly patients
    Elaheh Abiri, Mehdi Mirzaii, Majid Moghbeli, Amir Atashi, Ahad Ali Harati · 2024 · BMC Infectious Diseases
  76. Analysis of effector/memory regulatory T cells from arrhythmogenic cardiomyopathy patients identified IL-32 as a novel player in ACM pathogenesis
    Salwa Soussi, Angela Serena Maione, Lise Lefèvre, Nathalie Pizzinat, Jason S. Iacovoni, Ignacio Gonzalez-Fuentes, Daniel Cussac, Lara Iengo, Yohan Santin, Fabrizio Tundo et al. · 2025 · Cell Death and Disease
  77. A Biomarker-Centric Approach to Drug Discovery and Development: Lessons Learned from the Coronavirus Disease 2019 Pandemic
    Kelly Alana Fader, Jiangwei Zhang, Joseph P. Menetski, Ravi Thadhani, Elliott Marshall Antman, Gary S. Friedman, Shashi K. Ramaiah, Vishal S. Vaidya · 2020 · Journal of Pharmacology and Experimental Therapeutics
  78. Beneficial ex vivo immunomodulatory and clinical effects of clarithromycin in COVID-19
    Timothy Arthur Chandos Snow, Alessia Longobardo, David A. Brealey, Jim Down, Giovanni Satta, Mervyn Singer, Nishkantha Arulkumaran · 2022 · Journal of Infection and Chemotherapy
  79. T helper cell subsets and related target cells in acute COVID-19
    Igor Vladimirovich Kudryavtsev, А. С. Головкин, Арег А. Тотолян · 2022 · Russian Journal of Infection and Immunity
  80. New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer
    Susan Costantini, Gabriele Madonna, Elena Di Gennaro, Francesca Capone, Palmina Bagnara, Mariaelena Capone, Silvia Sale, Carmine Nicastro, Lidia Atripaldi, Giuseppe Fiorentino et al. · 2023 · International Journal of Molecular Sciences
  81. Flow cytometry profiling of cellular immune response in COVID-19 infected, recovered and vaccinated individuals
    Diksha Kumari, Sayar Singh, Manisha Kumari, Harshita Gupta, Deepika Chauhan, Karuna Singh, Malleswara Rao Eslavath, Brij Bhushan, Vikas Dogra, Mona Bargotya et al. · 2023 · Immunobiology
  82. Multi-omic profiling reveals early immunological indicators for identifying COVID-19 Progressors
    Katherine Drake, Dimitri Talantov, Gary J. Tong, Jack T. Lin, Simon Verheijden, Samuel Katz, Jacqueline M. Leung, Benjamin Yuen, Vinod Krishna, Michelle J. Wu et al. · 2023 · Clinical Immunology
  83. The single-cell landscape of immunological responses of CD4+ T cells in HIV versus severe acute respiratory syndrome coronavirus 2
    Jack A. Collora, Runxia Liu, Kristen Albrecht, Ya‐Chi Ho · 2020 · Current Opinion in HIV and AIDS
  84. A Dynamic Bayesian Model for Identifying High-Mortality Risk in Hospitalized COVID-19 Patients
    Amir Momeni Boroujeni, Rachelle Mendoza, Isaac J. Stopard, Ben C. Lambert, Alejandro R. Zuretti · 2021 · Infectious Disease Reports
  85. Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in COVID-19 Patients: Report of a Structured Multidisciplinary Consensus
    Irene Coloretti, Giorgio Berlot, Stefano Busani, Francesco Giuseppe De Rosa, Abele Donati, Francesco Forfori, Giacomo Grasselli, Lucia Mirabella, Carlo Tascini, Pierluigi Viale et al. · 2021 · Journal of Clinical Medicine
  86. COV-BT Ire study: safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with brain tumors
    Antonio Tanzilli, Andrea Pace, Gennaro Ciliberto, Antonia Marina La Malfa, Valentina Buonomo, Dario Benincasa, Annamaria Biscu, Edvina Galiè, Veronica Villani · 2022 · Neurological Sciences
  87. Cholinergic and lipid mediators crosstalk in Covid-19 and the impact of glucocorticoid therapy
    Malena M. Pérez, Vinícius E. Pimentel, Carlos Alessandro Fuzo, Pedro Vieira Da Silva-Neto, Diana Mota Toro, Camila Oliveira Silva Souza, Thais Fernanda de Campos Fraga‐Silva, Luiz Gustavo Gardinassi, Jonatan C. S. de Carvalho, Nicola T. Neto et al. · 2021 · medRxiv
  88. Immune Response in COVID-19-associated Acute Kidney Injury and Maladaptive Kidney Repair
    Ying Fu, Zheng Dong · 2023 · Integrative Medicine in Nephrology and Andrology
  89. Characterization of Collaborative Cross mouse founder strain CAST/EiJ as a novel model for lethal COVID-19
    Candice N. Baker, Debra K. Duso, Naga Rama Kothapalli, Tricia Hart, Sean Casey, Tres S. Cookenham, Larry W. Kummer, Janine Hvizdos, Kathleen G. Lanzer, Purva Vats et al. · 2024 · Scientific Reports
  90. Distinct immune cell profiles associated with high‐altitude hypoxia and severe acute mountain sickness
    Jingxuan Han, Jian Gao, Yanyun Ma, Yi Li, Chenyuan Wu, Shiguan Le, Yiran Zhao, Helian Li, Yali Luo, Xuling Han et al. · 2025 · The Journal of Physiology
  91. Early Recognition of Low-Risk SARS-CoV-2 Pneumonia
    Rosario Menéndez, Raúl Méndez, Paula González‐Jiménez, Rafael Zalacaín, Luis Alberto Ruiz, Leyre Serrano Fernández, Pedro Pablo España, Ane Uranga, Catia Cillóniz, Luis Pérez de Llano et al. · 2022 · CHEST Journal
  92. Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression in vivo
    Nicholas J. Tursi, Ziyang Xu, Michaela Helble, Susanne N. Walker, Kevin Liaw, Neethu Chokkalingam, Toshitha Kannan, Yuanhan Wu, Edgar Tello‐Ruiz, Daniel H. Park et al. · 2023 · Frontiers in Immunology
  93. Decreased progenitor TCF1 + T-cells correlate with COVID-19 disease severity
    Thai Hien Tu, Ami Grunbaum, François Santinon, Alexandra Kazanova, Nicholas Rozza, Richard B. Kremer, Catalin Liviu Dragos Mihalcioiu, Christopher E. Rudd · 2024 · Communications Biology
  94. Eosinophils and COVID‐19: Insights into immune complexity and vaccine safety
    W. Sahli, Joana Vitte, Benoît Desnues · 2025 · Clinical and Translational Allergy
  95. Tapping the immunological imprints to design chimeric SARS-CoV-2 vaccine for elderly population
    Asim Biswas, Rahul Shubhra Mandal, Suparna Chakraborty, George Maiti · 2021 · International Reviews of Immunology
  96. Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized Medicine
    Jules Russick, Pierre-Emmanuel Foy, Nathalie Josseaume, Maxime Meylan, Nadine Benhamouda, Amos Kirilovsky, Carine El Sissy, Éric Tartour, David M. Smadja, Alexandre Karras et al. · 2021 · Frontiers in Immunology
  97. COVID ‐19: Using high‐throughput flow cytometry to dissect clinical heterogeneity
    Irene del Molino del Barrio, Thomas S. Hayday, Adam G. Laing, Adrian Hayday, Francesca Di Rosa · 2021 · Cytometry Part A
  98. Envelope‐based partial partial least squares with application to cytokine‐based biomarker analysis for COVID‐19
    Yeonhee Park, Zhihua Su, Dongjun Chung · 2022 · Statistics in Medicine
  99. Comprehensive Cytokine Profiling of Patients with COVID-19 Receiving Tocilizumab Therapy
    Аnna Lebedeva, Ivan A. Molodtsov, Alexandra Anisimova, Anastasia Berestovskaya, Oleg Dukhin, Antonina Elizarova, Wendy Fitzgerald, Daria S. Fomina, Kseniya A. Glebova, Oxana Ivanova et al. · 2022 · International Journal of Molecular Sciences
  100. Defying convention in the time of COVID-19: Insights into the role of γδ T cells
    Marta Sanz, Brendan T. Mann, Alisha Chitrakar, Natalia Soriano-Sarabia · 2022 · Frontiers in Immunology